Matches in Wikidata for { <http://www.wikidata.org/entity/Q37405405> ?p ?o ?g. }
- Q37405405 description "2013 թվականի հոկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q37405405 description "article científic" @default.
- Q37405405 description "article scientifique" @default.
- Q37405405 description "articolo scientifico" @default.
- Q37405405 description "artigo científico" @default.
- Q37405405 description "artículu científicu espublizáu en 2013" @default.
- Q37405405 description "bilimsel makale" @default.
- Q37405405 description "scientific article published on 10 October 2013" @default.
- Q37405405 description "vedecký článok" @default.
- Q37405405 description "vetenskaplig artikel" @default.
- Q37405405 description "videnskabelig artikel" @default.
- Q37405405 description "vědecký článek" @default.
- Q37405405 description "wetenschappelijk artikel" @default.
- Q37405405 description "wissenschaftlicher Artikel" @default.
- Q37405405 description "наукова стаття, опублікована в жовтні 2013" @default.
- Q37405405 description "научни чланак" @default.
- Q37405405 description "مقالة علمية نشرت في 10 أكتوبر 2013" @default.
- Q37405405 name "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 name "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 name "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35." @default.
- Q37405405 type Item @default.
- Q37405405 label "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 label "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 label "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35." @default.
- Q37405405 prefLabel "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 prefLabel "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 prefLabel "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35." @default.
- Q37405405 P1433 Q37405405-731564BE-34DC-4113-B2CD-CF58DBA96DB8 @default.
- Q37405405 P1476 Q37405405-F64F2A8D-55CC-481F-8075-3A4164DE3365 @default.
- Q37405405 P2093 Q37405405-1D39FBEE-41B9-41A4-BAAB-3B038E8F0159 @default.
- Q37405405 P2093 Q37405405-44686DF1-4560-47D4-B7B4-A95ED8F61763 @default.
- Q37405405 P2093 Q37405405-493DAFAE-BA9D-4C36-B22F-0504552B5C6F @default.
- Q37405405 P2093 Q37405405-707263F4-1499-4F14-8752-89E06B43E509 @default.
- Q37405405 P2093 Q37405405-88B259EA-6930-483B-A010-DDDB2465E0D3 @default.
- Q37405405 P2093 Q37405405-BE465539-55EB-426E-B61F-B5DD258252FF @default.
- Q37405405 P2093 Q37405405-DFD98DDA-64A7-470C-AE3D-DAE14475578E @default.
- Q37405405 P2860 Q37405405-0727EC2D-BBED-4174-AB18-6A02FE032E85 @default.
- Q37405405 P2860 Q37405405-0A4AF08D-8744-4B9D-811C-03612194B3A9 @default.
- Q37405405 P2860 Q37405405-1264F926-6EFF-41A7-9190-1A8667BC04A1 @default.
- Q37405405 P2860 Q37405405-139808F9-2AE2-4C33-A276-AD5B2C589299 @default.
- Q37405405 P2860 Q37405405-1CE2CCDA-B5A5-4D54-8E32-109671DE77F5 @default.
- Q37405405 P2860 Q37405405-252D2550-7FC7-4F0B-AA7A-EB157917B12B @default.
- Q37405405 P2860 Q37405405-2A99C8AB-B6EF-43C0-9CB7-C41A604EF9AE @default.
- Q37405405 P2860 Q37405405-2C4F7A89-78C8-4621-8246-ECE8BA7D489D @default.
- Q37405405 P2860 Q37405405-2CCA5AFF-43AF-4367-85D9-CA042C951EEE @default.
- Q37405405 P2860 Q37405405-37C2BCA6-DDBA-425D-80C4-D0BB94BD069E @default.
- Q37405405 P2860 Q37405405-4B8F0AE9-FCA9-4A13-A60D-A3A9DFE8C7CF @default.
- Q37405405 P2860 Q37405405-4FDEA673-9B9E-4188-9904-E33C62668462 @default.
- Q37405405 P2860 Q37405405-5D034F47-9008-46B8-A07E-3B117D9BAAFE @default.
- Q37405405 P2860 Q37405405-620A6E1C-3E3B-4E82-A002-39D9C5554885 @default.
- Q37405405 P2860 Q37405405-68B34218-7D33-421A-8391-3657B0C6172B @default.
- Q37405405 P2860 Q37405405-75817F56-E96C-40DB-B167-0E375DF6D564 @default.
- Q37405405 P2860 Q37405405-7C57DDE8-5D28-438F-9EF4-D7F3A118E639 @default.
- Q37405405 P2860 Q37405405-8413F93A-2475-457A-AA9A-8BCDBD75DFF8 @default.
- Q37405405 P2860 Q37405405-8E913FE5-BE58-43E1-887E-21F4F142A823 @default.
- Q37405405 P2860 Q37405405-A8800ECA-0141-4FBA-A72A-9F19439D2A49 @default.
- Q37405405 P2860 Q37405405-ADA111BC-84F6-475A-9579-7D9CB16BDCF1 @default.
- Q37405405 P2860 Q37405405-AEB6A4CE-7D73-4FB6-808C-E88120BFD035 @default.
- Q37405405 P2860 Q37405405-B89D137A-4693-4958-A86C-C1389577DC3D @default.
- Q37405405 P2860 Q37405405-C95B7F04-C921-4E47-A496-D03B71EF534D @default.
- Q37405405 P2860 Q37405405-CB8789B0-53CC-47B3-B89E-DBD3B944F33F @default.
- Q37405405 P2860 Q37405405-CBE41CB7-57F6-4BE1-8E25-66E3CD533D5F @default.
- Q37405405 P2860 Q37405405-D33CD5F0-68D5-4EA1-942F-C0EFA7262009 @default.
- Q37405405 P2860 Q37405405-DDE8D7B4-09BB-4529-8AEB-51ADED8059E2 @default.
- Q37405405 P2860 Q37405405-E61B04EF-1EB9-4C7A-8700-588767D47A8F @default.
- Q37405405 P304 Q37405405-E62B339D-4AE3-414A-91E0-D2AF3B631A0B @default.
- Q37405405 P31 Q37405405-32B0E4A0-C54C-40E3-8B5E-CC46D558A0D8 @default.
- Q37405405 P356 Q37405405-68A9FD08-A9DE-494A-B7DB-9B399F7E0526 @default.
- Q37405405 P433 Q37405405-3A658265-F2E6-47E7-A2FF-AD3F47E5CC42 @default.
- Q37405405 P478 Q37405405-B11339A4-8EE0-4722-960F-3962E0F40E9F @default.
- Q37405405 P50 Q37405405-10DEE079-7C2F-4D5E-88D0-A85467F16808 @default.
- Q37405405 P50 Q37405405-58A675BE-32D2-4D79-937C-9B59212B2C9F @default.
- Q37405405 P50 Q37405405-8FE1C938-41A9-4350-872B-B8120DC25521 @default.
- Q37405405 P50 Q37405405-D14BCF4E-398A-4A83-9A6B-7BF2125760BB @default.
- Q37405405 P577 Q37405405-A8F1EF89-27AD-4817-B7A3-9CF8DC62EC75 @default.
- Q37405405 P5875 Q37405405-1680B0C8-DDAF-44D6-9E40-49AFB80768BC @default.
- Q37405405 P698 Q37405405-CC3F03DC-972C-4C20-94CA-BAB7CA0C9961 @default.
- Q37405405 P921 Q37405405-2CC56456-368A-4ADE-A0F8-F66197671996 @default.
- Q37405405 P932 Q37405405-64CDD3BC-7257-48F7-8CDD-63FC079A3B65 @default.
- Q37405405 P356 MOL.113.089482 @default.
- Q37405405 P698 24113750 @default.
- Q37405405 P1433 Q1943386 @default.
- Q37405405 P1476 "The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35" @default.
- Q37405405 P2093 "Amanda E MacKenzie" @default.
- Q37405405 P2093 "Gianluigi Caltabiano" @default.
- Q37405405 P2093 "Jennifer E McCallum" @default.
- Q37405405 P2093 "Laura Jenkins" @default.
- Q37405405 P2093 "Lindsay Fawcett" @default.
- Q37405405 P2093 "Rachel Markwick" @default.
- Q37405405 P2093 "Toby C Kent" @default.
- Q37405405 P2860 Q22251082 @default.
- Q37405405 P2860 Q24338794 @default.
- Q37405405 P2860 Q24605869 @default.
- Q37405405 P2860 Q24617794 @default.
- Q37405405 P2860 Q27675402 @default.
- Q37405405 P2860 Q27860712 @default.
- Q37405405 P2860 Q27860944 @default.
- Q37405405 P2860 Q28302327 @default.
- Q37405405 P2860 Q28943462 @default.
- Q37405405 P2860 Q30990011 @default.